1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends
  4. > Ablation Technologies Market by Product & Application - Global Forecasts to 2020

The global ablation technologies market is estimated to grow at a CAGR of 10.5% from 2015 to 2020 and will be valued at USD 4.44 billion. Although mature markets (such as the U.S., Germany, France, and the U.K.) held larger shares in the ablation technologies market in 2015, the Asia-Pacific region is poised to grow at the highest CAGR in the next five years. Factors such as growing popularity of minimally invasive surgeries, government efforts to increase population access for elective surgeries, rising focus of global players, large population base and improving healthcare infrastructure and the rising focus of international and domestic players on the Asia-Pacific ablation technologies market are propelling its growth.

The growth of the ablation technologies market is driven by factors such as increasing number of ablation procedures, rising incidence of cancer, growing prevalence of cardiovascular diseases, emergence of next-generation ablation products and technologies, growing adoption of minimally-invasive procedures, increasing number of hospitals, surgical, and ablation centers and improving reimbursement scenario in established markets. However, factors such as reuse and reprocessing of devices in developing countries, Healthcare cost-containment measures, and ongoing healthcare reforms in the U.S. are restraining the growth of the market. Increasing funding for the development of novel ablation devices, emerging markets such as China, India, and Mexico are creating opportunities for the players involved in the ablation technologies market.

In this report, the global ablation technologies market has been segmented on the basis of type of product (light/laser ablators, radiofrequency ablators, electrical ablators, ultrasound ablators, microwave ablators, cryoablation devices, and hydrothermal ablators), type of technology (light/laser, radiofrequency, electrical, ultrasound, microwave, cryoblation, and hydrothermal technologies), and type of application (cancer, cardiovascular, gynecological, ophthalmological, urological, orthopedic, pain management and cosmetic surgery). The radiofrequency ablators market is estimated to account for the largest share of the global ablation technologies market in 2015, followed by the light/laser ablators market. Use of RF ablators in primary interventional therapy for the treatment of many cardiac arrhythmias is a key factor driving the segment. Better temperature control by RF ablators as compared to other ablation products (such as electrical and microwave ablators), clinical advantages offered by temperature-controlled RF ablators over traditional ablation approaches are further supporting the growth of the segment.

The microwave ablators segment is estimated to grow at the highest CAGR from 2015 to 2020. This high growth is primarily due to its high success rate in cancer treatment as well as advantages offered by microwave ablation over RF ablation (for example, microwave ablation devices can produce larger ablation zones and do not suffer as much from the heat sink effect that can handicap RF ablation).


Geographically, North America (comprising the U.S. and Canada) commands the largest share of the global ablation technologies market in 2015, followed by Europe. The ablation technologies market in North America is primarily driven by various factors including presence of a large number of ablation product manufacturers, significant rate of adoption of ablation treatment, large patient population base, growing demand for minimally invasive surgical procedures and continuously rising prevalence of chronic disorders such as cancer and heart diseases (especially atrial fibrillation).

The global ablation technologies market is highly competitive, with a large number of global and local players. As of 2014, the global ablation technologies market was dominated by Medtronic, Inc. (Ireland), Biosense Webster, Inc. (U.S.), St. Jude Medical, Inc. (U.S.), and Boston Scientific Corporation (U.S.), which together accounted for ~50% of the market. New product launches, pipeline product enhancements, and partnerships, agreements, and joint ventures are the major strategies adopted by most of the market players to achieve growth in the ablation technologies market.

Reasons to Buy the Report:

From an insight perspective, this research report has focused on various levels of analysis —industry analysis (industry trends, PEST analysis, and Porter’s five force model), market share analysis of top ten players, and company profiles, which together comprise and discuss basic views on the competitive landscape, emerging and high-growth segments of the ablation technologies market, high-growth regions and countries and their respective drivers, restraints, challenges, and opportunities.

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms in garnering a greater market share. Firms purchasing the report could use any one or combination of the below mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market share.

The report provides insights on the following pointers:

- Market Penetration: Comprehensive information on ablation devices offered by the top 10 players in the ablation technologies market. The report analyzes the ablation technologies market by type of product, technology, and application across geographies

- Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and new product launches in the ablation technologies market

- Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various ablation devices across geographies

- Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the ablation technologies market

- Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of leading players in the ablation technologies market

Table Of Contents

Ablation Technologies Market by Product and Application - Global Forecasts to 2020
TABLE OF CONTENTS

1 INTRODUCTION 16
1.1 OBJECTIVES OF THE STUDY 16
1.2 MARKET DEFINITION 16
1.3 MARKET SCOPE 16
1.4 MARKETS COVERED 17
1.4.1 YEARS CONSIDERED FOR THE STUDY 18
1.5 CURRENCY 18
1.6 STAKEHOLDERS 19
2 RESEARCH METHODOLOGY 20
2.1 RESEARCH METHODOLOGY STEPS 20
2.2 SECONDARY AND PRIMARY RESEARCH METHODOLOGY 21
2.2.1 SECONDARY RESEARCH 21
2.2.1.1 Key data from secondary sources 21
2.2.2 PRIMARY RESEARCH 22
2.2.2.1 Key data from primary sources 23
2.2.3 MARKET SIZE ESTIMATION METHODOLOGY 24
2.2.4 RESEARCH METHODOLOGY: TOP-DOWN APPROACH 24
2.2.5 RESEARCH METHODOLOGY: BOTTOM-UP APPROACH 25
2.3 RESEARCH DESIGN 25
2.4 MARKET DATA VALIDATION AND TRIANGULATION 26
2.4.1 ASSUMPTIONS FOR THE STUDY 27
3 EXECUTIVE SUMMARY 28
3.1 INTRODUCTION 28
3.2 CURRENT MARKET SCENARIO 28
3.3 FUTURE OUTLOOK 29
3.4 CONCLUSION 32
4 PREMIUM INSIGHTS 33
4.1 GLOBAL ABLATION TECHNOLOGIES MARKET OVERVIEW (2015-2020) 33
4.2 GEOGRAPHICAL SNAPSHOT OF THE GLOBAL ABLATION TECHNOLOGIES MARKET 34
4.3 GLOBAL ABLATION TECHNOLOGIES MARKET, BY TYPE AND REGION (2015) 35
4.4 GLOBAL ABLATION TECHNOLOGIES MARKET, BY APPLICATION AND REGION (2015 VS. 2020) 36
4.5 GLOBAL ABLATION TECHNOLOGIES MARKET SIZE, BY PRODUCT (2015 VS. 2020) 36

5 MARKET OVERVIEW 37
5.1 INTRODUCTION 37
5.2 MARKET SEGMENTATION 37
5.3 MARKET DYNAMICS 38
5.3.1 DRIVERS 38
5.3.1.1 Increasing number of ablation procedures 38
5.3.1.2 Rising incidence of cancer 39
5.3.1.3 Growing prevalence of cardiovascular diseases 40
5.3.1.4 Emergence of next-generation ablation products and technologies 40
5.3.1.5 Growing adoption of minimally invasive procedures 41
5.3.1.6 Increasing number of hospitals, surgical, and ablation centers 41
5.3.1.7 Improving reimbursement scenario in established markets 42
5.3.2 RESTRAINTS 43
5.3.2.1 Reuse and reprocessing of devices in developing countries 43
5.3.2.2 Healthcare cost-containment measures 43
5.3.3 CHALLENGES 44
5.3.3.1 Stringent regulatory guidelines 44
5.3.3.2 Therapeutic challenges 45
5.3.4 OPPORTUNITIES 45
5.3.4.1 Increasing funding for the development of novel ablation devices 45
5.3.4.2 Emerging markets 46
5.3.4.3 Rising number of training programs 46
5.3.5 TRENDS 47
5.3.5.1 Market consolidation 47
5.3.5.2 Increasing focus of global players towards developing nations 47
6 GLOBAL ABLATION TECHNOLOGIES MARKET, BY TYPE 49
6.1 INTRODUCTION 50
6.2 RADIOFREQUENCY ABLATION 52
6.3 LASER/LIGHT ABLATION 53
6.4 ULTRASOUND ABLATION 54
6.5 ELECTRICAL ABLATION 55
6.6 CRYOABLATION 56
6.7 MICROWAVE ABLATION 57
6.8 HYDROTHERMAL ABLATION 58
7 GLOBAL ABLATION TECHNOLOGIES MARKET, BY PRODUCT 60
7.1 INTRODUCTION 61
7.2 RADIOFREQUENCY ABLATORS 62
7.2.1 TEMPERATURE-CONTROLLED RADIOFREQUENCY ABLATORS 63
7.2.2 FLUID-COOLED RADIOFREQUENCY ABLATORS 64
7.2.3 ROBOTIC CATHETER MANIPULATION SYSTEMS 65
7.3 LASER/LIGHT ABLATORS 66
7.3.1 EXCIMER LASER ABLATORS 66
7.3.2 COLD LASER ABLATORS 67
7.4 ULTRASOUND ABLATORS 68
7.4.1 ULTRASONIC SURGICAL ABLATION SYSTEMS 68
7.4.2 HIGH-INTENSITY FOCUSED ULTRASOUND (HIFU) ABLATORS 69
7.4.3 EXTRACORPOREAL SHOCKWAVE LITHOTRIPSY (ESWL) SYSTEMS 70
7.4.4 MAGNETIC RESONANCE-GUIDED FOCUSED ULTRASOUND (MRGFUS) ABLATORS 71
7.5 ELECTRICAL ABLATORS 72
7.5.1 ARGON PLASMA/BEAM COAGULATORS 72
7.5.2 IRREVERSIBLE ELECTROPORATION ABLATORS 73
7.6 CRYOABLATION DEVICES 74
7.6.1 TISSUE CONTACT PROBES 75
7.6.2 TISSUE SPRAY PROBES 76
7.6.3 EPIDERMAL AND SUBCUTANEOUS CRYOABLATION DEVICES 76
7.7 MICROWAVE ABLATORS 77
7.7.1 MICROWAVE THERMOTHERAPY DEVICES 78
7.8 HYDROTHERMAL ABLATORS 79
7.8.1 ENDOMETRIAL HYDROTHERMAL BALLOON ABLATION DEVICES 79
8 GLOBAL ABLATION TECHNOLOGIES MARKET, BY APPLICATION 80
8.1 INTRODUCTION 81
8.2 CARDIOVASCULAR DISEASE TREATMENT 82
8.3 CANCER TREATMENT 84
8.3.1 LIVER CANCER 84
8.3.2 KIDNEY CANCER 84
8.3.3 PROSTATE CANCER 84
8.3.4 LUNG CANCER 84
8.3.5 BONE METASTASIS 85
8.3.6 BREAST CANCER 85
8.4 OPHTHALMOLOGIC TREATMENT 85
8.5 PAIN MANAGEMENT 87
8.6 GYNECOLOGICAL TREATMENT 88
8.7 UROLOGICAL TREATMENT 89
8.8 ORTHOPEDIC TREATMENT 90
8.9 COSMETIC/ AESTHETIC SURGERY 91
8.10 OTHER TREATMENTS 92

9 GLOBAL ABLATION TECHNOLOGIES MARKET, BY REGION 94
9.1 INTRODUCTION 95
9.2 NORTH AMERICA 96
9.2.1 U.S. 100
9.2.2 CANADA 101
9.3 EUROPE 103
9.3.1 GERMANY 106
9.3.2 FRANCE 108
9.3.3 U.K. 109
9.3.4 REST OF EUROPE 110
9.4 ASIA-PACIFIC 112
9.4.1 JAPAN 115
9.4.2 CHINA 116
9.4.3 INDIA 118
9.4.4 REST OF ASIA-PACIFIC 119
9.5 REST OF THE WORLD 120
10 COMPETITIVE LANDSCAPE 123
10.1 OVERVIEW 123
10.2 MARKET SHARE ANALYSIS 124
10.2.1 KEY PLAYERS IN THE ABLATION TECHNOLOGIES MARKET 124
10.3 COMPETITIVE SITUATION AND TRENDS 125
10.3.1 NEW PRODUCT LAUNCHES and APPROVALS 125
10.3.2 MERGERS and ACQUISITIONS 126
10.3.3 GEOGRAPHICAL EXPANSIONS 127
10.3.4 AGREEMENTS AND JOINT VENTURES 129
10.3.5 OTHER DEVELOPMENTS 129
11 COMPANY PROFILES 131
11.1 INTRODUCTION 131
11.2 MEDTRONIC PLC 132
11.3 BIOSENSE WEBSTER, INC. (A SUBSIDIARY OF JOHNSON and JOHNSON INC.) 138
11.4 ST. JUDE MEDICAL, INC. 141
11.5 BOSTON SCIENTIFIC CORPORATION 145
11.6 ANGIODYNAMICS, INC. 148
11.7 ATRICURE, INC. 151
11.8 CONMED CORPORATION 154
11.9 OLYMPUS CORPORATION 156
11.10 SMITH and NEPHEW 158
11.11 GALIL MEDICAL INC. 160
*Details On Financials, Products and Services, Key Strategy, and Recent Developments Might Not Be Captured In Case Of Unlisted Companies.
12 APPENDIX 162
12.1 INSIGHTS OF INDUSTRY EXPERTS 162
12.2 DISCUSSION GUIDE 163
12.3 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 167
12.4 AVAILABLE CUSTOMIZATIONS 168
12.5 RELATED REPORTS 168


LIST OF TABLES

TABLE 1 GLOBAL ABLATION TECHNOLOGIES MARKET SIZE, BY TYPE,
2013-2020 (USD MILLION) 51
TABLE 2 ABLATION TECHNOLOGIES MARKET SIZE, BY REGION, 2013-2020 (USD MILLION) 51
TABLE 3 RADIOFREQUENCY ABLATION MARKET SIZE, BY REGION,
2013-2020 (USD MILLION) 53
TABLE 4 LASER/LIGHT ABLATION MARKET SIZE, BY REGION, 2013-2020 (USD MILLION) 54
TABLE 5 ULTRASOUND ABLATION MARKET SIZE, BY REGION, 2013-2020 (USD MILLION) 55
TABLE 6 ELECTRICAL ABLATION MARKET SIZE, BY REGION, 2013-2020 (USD MILLION) 56
TABLE 7 CRYOABLATION MARKET SIZE, BY REGION, 2013-2020 (USD MILLION) 57
TABLE 8 MICROWAVE ABLATION MARKET SIZE, BY REGION, 2013-2020 (USD MILLION) 58
TABLE 9 HYDROTHERMAL ABLATION MARKET SIZE, BY REGION,
2013-2020 (USD MILLION) 59
TABLE 10 GLOBAL ABLATION TECHNOLOGIES MARKET SIZE, BY PRODUCT,
2013-2020 (USD MILLION) 62
TABLE 11 RADIOFREQUENCY ABLATORS MARKET SIZE, BY PRODUCT,
2013-2020 (USD MILLION) 62
TABLE 12 RADIOFREQUENCY ABLATORS MARKET SIZE, BY REGION,
2013-2020 (USD MILLION) 63
TABLE 13 TEMPERATURE-CONTROLLED RADIOFREQUENCY ABLATORS MARKET SIZE,
BY REGION, 2013-2020 (USD MILLION) 64
TABLE 14 FLUID-COOLED RADIOFREQUENCY ABLATORS MARKET SIZE, BY REGION,
2013-2020 (USD MILLION) 65
TABLE 15 ROBOTIC CATHETER MANIPULATION SYSTEMS MARKET SIZE, BY REGION,
2013-2020 (USD MILLION) 65
TABLE 16 LASER/LIGHT ABLATORS MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION) 66
TABLE 17 LASER/LIGHT ABLATORS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION) 66
TABLE 18 EXCIMER LASER ABLATORS MARKET SIZE, BY REGION,
2013-2020 (USD MILLION) 67
TABLE 19 COLD LASER ABLATORS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION) 67
TABLE 20 ULTRASOUND ABLATORS MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION) 68
TABLE 21 ULTRASOUND ABLATORS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION) 68
TABLE 22 ULTRASONIC SURGICAL ABLATION SYSTEMS MARKET SIZE, BY REGION,
2013-2020 (USD MILLION) 69
TABLE 23 HIGH-INTENSITY FOCUSED ULTRASOUND ABLATORS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION) 70
TABLE 24 EXTRACORPOREAL SHOCKWAVE LITHOTRIPSY SYSTEMS MARKET SIZE,
BY REGION, 2013-2020 (USD MILLION) 70
TABLE 25 MAGNETIC RESONANCE-GUIDED FOCUSED ULTRASOUND ABLATORS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION) 71
TABLE 26 ELECTRICAL ABLATORS MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION) 72
TABLE 27 ELECTRICAL ABLATORS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION) 72
TABLE 28 ARGON PLASMA/BEAM COAGULATORS MARKET SIZE, BY REGION,
2013-2020 (USD MILLION) 73
TABLE 29 IRREVERSIBLE ELECTROPORATION ABLATORS MARKET SIZE, BY REGION,
2013-2020 (USD MILLION) 74
TABLE 30 CRYOABLATION DEVICES MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION) 74
TABLE 31 CRYOABLATION DEVICES MARKET SIZE, BY REGION, 2013-2020 (USD MILLION) 75
TABLE 32 TISSUE CONTACT PROBES MARKET SIZE, BY REGION, 2013-2020 (USD MILLION) 75
TABLE 33 TISSUE SPRAY PROBES MARKET SIZE, BY REGION, 2013-2020 (USD MILLION) 76
TABLE 34 EPIDERMAL AND SUBCUTANEOUS CRYOABLATION DEVICES MARKET SIZE,
BY REGION, 2013-2020 (USD MILLION) 77
TABLE 35 MICROWAVE ABLATORS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION) 77
TABLE 36 HYDROTHERMAL ABLATORS MARKET SIZE, BY REGION,
2013-2020 (USD MILLION) 79
TABLE 37 GLOBAL ABLATION TECHNOLOGIES MARKET SIZE, BY APPLICATION,
2013-2020 (USD MILLION) 82
TABLE 38 ABLATION TECHNOLOGIES MARKET SIZE FOR CARDIOVASCULAR DISEASE TREATMENT, BY REGION, 2013-2020 (USD MILLION) 83
TABLE 39 ABLATION TECHNOLOGIES MARKET SIZE FOR CANCER TREATMENT, BY REGION, 2013-2020 (USD MILLION) 85
TABLE 40 ABLATION TECHNOLOGIES MARKET SIZE FOR OPHTHALMOLOGIC TREATMENT,
BY REGION, 2013-2020 (USD MILLION) 86
TABLE 41 ABLATION TECHNOLOGIES MARKET SIZE FOR PAIN MANAGEMENT,
BY REGION, 2013-2020 (USD MILLION) 87
TABLE 42 ABLATION TECHNOLOGIES MARKET SIZE FOR GYNECOLOGICAL TREATMENT,
BY REGION, 2013-2020 (USD MILLION) 88
TABLE 43 ABLATION TECHNOLOGIES MARKET SIZE FOR UROLOGIC TREATMENT,
BY REGION, 2013-2020 (USD MILLION) 89
TABLE 44 ABLATION TECHNOLOGIES MARKET SIZE FOR ORTHOPEDIC TREATMENT,
BY REGION, 2013-2020 (USD MILLION) 90
TABLE 45 ABLATION TECHNOLOGIES MARKET SIZE FOR COSMETIC/ AESTHETIC SURGERY, BY REGION, 2013-2020 (USD MILLION) 92
TABLE 46 ABLATION TECHNOLOGIES MARKET SIZE FOR OTHER TREATMENTS, BY REGION, 2013-2020 (USD MILLION) 93
TABLE 47 GLOBAL ABLATION TECHNOLOGIES MARKET SIZE, BY REGION,
2013-2020 (USD MILLION) 96
TABLE 48 NORTH AMERICA: ABLATION TECHNOLOGIES MARKET SIZE, BY COUNTRY,
2013-2020 (USD MILLION) 98
TABLE 49 NORTH AMERICA: ABLATION TECHNOLOGIES MARKET SIZE, BY TYPE,
2013-2020 (USD MILLION) 99
TABLE 50 NORTH AMERICA: ABLATION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION) 99
TABLE 51 U.S.: ABLATION TECHNOLOGIES MARKET SIZE, BY TYPE,
2013-2020 (USD MILLION) 101
TABLE 52 CANADA: ABLATION TECHNOLOGIES MARKET SIZE, BY TYPE,
2013-2020 (USD MILLION) 102
TABLE 53 EUROPE: ABLATION TECHNOLOGIES MARKET SIZE, BY COUNTRY,
2013-2020 (USD MILLION) 105
TABLE 54 EUROPE: ABLATION TECHNOLOGIES MARKET SIZE, BY TYPE,
2013-2020 (USD MILLION) 105
TABLE 55 EUROPE: ABLATION TECHNOLOGIES MARKET SIZE, BY APPLICATION,
2013-2020 (USD MILLION) 106
TABLE 56 GERMANY: ABLATION TECHNOLOGIES MARKET SIZE, BY TYPE,
2013-2020 (USD MILLION) 107
TABLE 57 FRANCE: ABLATION TECHNOLOGIES MARKET SIZE, BY TYPE,
2013-2020 (USD MILLION) 109
TABLE 58 U.K.: ABLATION TECHNOLOGIES MARKET SIZE, BY TYPE,
2013-2020 (USD MILLION) 110
TABLE 59 REST OF EUROPE: ABLATION TECHNOLOGIES MARKET SIZE, BY TYPE,
2013-2020 (USD MILLION) 111
TABLE 60 ASIA-PACIFIC: ABLATION TECHNOLOGIES MARKET SIZE, BY COUNTRY,
2013-2020 (USD MILLION) 114
TABLE 61 ASIA-PACIFIC: ABLATION TECHNOLOGIES MARKET SIZE, BY TYPE,
2013-2020 (USD MILLION) 114
TABLE 62 ASIA-PACIFIC: ABLATION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 20130Û2020 (USD MILLION) 115
TABLE 63 JAPAN: ABLATION TECHNOLOGIES MARKET SIZE, BY TYPE,
2013-2020 (USD MILLION) 116
TABLE 64 CHINA: ABLATION TECHNOLOGIES MARKET SIZE, BY TYPE,
2013-2020 (USD MILLION) 117
TABLE 65 INDIA: ABLATION TECHNOLOGIES MARKET SIZE, BY TYPE,
2013-2020 (USD MILLION) 118
TABLE 66 APAC: ABLATION TECHNOLOGIES MARKET SIZE, BY TYPE,
2013-2020 (USD MILLION) 120
TABLE 67 ROW: ABLATION TECHNOLOGIES MARKET SIZE, BY TYPE,
2013-2020 (USD MILLION) 121
TABLE 68 ROW: ABLATION TECHNOLOGIES MARKET SIZE, BY APPLICATION,
2013-2020 (USD MILLION) 122
TABLE 69 TOP 5 NEW PRODUCT LAUNCHES and APPROVALS, 2012-2015 126
TABLE 70 MERGERS and ACQUISITIONS, 2012-2015 127
TABLE 71 GEOGRAPHICAL EXPANSIONS, 2012-2015 128
TABLE 72 TOP 3 AGREEMENTS AND JOINT VENTURES, 2012-2015 129
TABLE 73 TOP 5 OTHER DEVELOPMENTS, 2012-2015 130


LIST OF FIGURES

FIGURE 1 GLOBAL ABLATION TECHNOLOGIES MARKET: RESEARCH METHODOLOGY STEPS 20
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION,
AND REGION 23
FIGURE 3 DATA TRIANGULATION METHODOLOGY 26
FIGURE 4 GLOBAL ABLATION TECHNOLOGIES MARKET SHARE, BY KEY PLAYER, 2014 29
FIGURE 5 ABLATION TECHNOLOGIES MARKET SIZE, BY TYPE (2015 VS. 2020) 30
FIGURE 6 ABLATION TECHNOLOGIES MARKET SHARE, BY PRODUCT (2015 VS. 2020) 30
FIGURE 7 ABLATION TECHNOLOGIES MARKET SIZE, BY APPLICATION (2015 VS. 2020) 31
FIGURE 8 ABLATION TECHNOLOGIES MARKET SHARE, BY REGION (2015) 32
FIGURE 9 RISING INCIDENCES OF CANCER and CARDIAC DISEASES—PRIMARY DRIVER OF THE ABLATION TECHNOLOGIES MARKET 33
FIGURE 10 INDIA AND CHINA ARE THE MOST LUCRATIVE MARKETS FOR ABLATION PRODUCT MANUFACTURERS 34
FIGURE 11 U.S. TO COMMAND THE LARGEST SHARE OF THE ABLATION TECHNOLOGIES MARKET IN 2015 35
FIGURE 12 CARDIOVASCULAR DISEASE TREATMENT SEGMENT TO DOMINATE THE ABLATION TECHNOLOGIES MARKET IN 2020 36
FIGURE 13 RADIOFREQUENCY ABLATORS WILL CONTINUE TO DOMINATE THE MARKET
TILL 2020 36
FIGURE 14 ABLATION TECHNOLOGIES MARKET SEGMENTATION 37
FIGURE 15 GLOBAL ABLATION TECHNOLOGIES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 38
FIGURE 16 GLOBAL PREVALENCE OF CANCER: EXPECTED TREND TILL 2020 39
FIGURE 17 INCREASING NUMBER OF ABLATION PROCEDURES PROPELLING THE MARKET GROWTH 43
FIGURE 18 COST-CONTAINMENT MEASURES BY GOVERNMENTS ARE RESTRAINING THE MARKET GROWTH FOR ABLATION DEVICES 44
FIGURE 19 STRINGENT REGULATORY GUIDELINES RESTRAIN THE GROWTH OF THE ABLATION TECHNOLOGIES MARKET 45
FIGURE 20 DEVELOPING COUNTRIES PAVE NEWER GROWTH AVENUES FOR MARKET PLAYERS 47
FIGURE 21 MICROWAVE ABLATION IS THE FASTEST-GROWING SEGMENT OF THE GLOBAL ABLATION TECHNOLOGIES MARKET 50
FIGURE 22 MICROWAVE ABLATION IS THE FASTEST-GROWING SEGMENT IN THE GLOBAL ABLATION TECHNOLOGIES MARKET 61
FIGURE 23 CARDIOVASCULAR DISEASE TREATMENT ABLATION MARKET TO GROW AT THE HIGHEST CAGR IN THE FORECAST PERIOD 81
FIGURE 24 GLOBAL ABLATION TECHNOLOGIES MARKET SHARE, BY COUNTRY (2015-2020) 95
FIGURE 25 NORTH AMERICA: ABLATION TECHNOLOGIES MARKET SNAPSHOT 97
FIGURE 26 EUROPE: ABLATION TECHNOLOGIES MARKET SNAPSHOT 104
FIGURE 27 ASIA-PACIFIC: ABLATION TECHNOLOGIES MARKET SNAPSHOT 113
FIGURE 28 LEADING MARKET PLAYERS ADOPTED NEW PRODUCT LAUNCHES and APPROVALS AS THEIR KEY GROWTH STRATEGY FROM 2012 TO 2015 123
FIGURE 29 GLOBAL ABLATION TECHNOLOGIES MARKET SHARE, BY KEY PLAYER, 2014 124
FIGURE 30 NEW PRODUCT LAUNCHES and APPROVALS WAS THE KEY STRATEGY 125
FIGURE 31 GEOGRAPHIC REVENUE MIX OF TOP MARKET PLAYERS 131
FIGURE 32 MEDTRONIC PLC: COMPANY SNAPSHOT 132
FIGURE 33 JOHNSON AND JOHNSON: COMPANY SNAPSHOT 138
FIGURE 34 ST. JUDE MEDICAL, INC.: COMPANY SNAPSHOT 141
FIGURE 35 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT 145
FIGURE 36 ANGIODYNAMICS, INC.: COMPANY SNAPSHOT 148
FIGURE 37 ATRICURE, INC.: COMPANY SNAPSHOT 151
FIGURE 38 CONMED CORPORATION: COMPANY SNAPSHOT 154
FIGURE 39 OLYMPUS CORPORATION: COMPANY SNAPSHOT 156
FIGURE 40 SMITH and NEPHEW: COMPANY SNAPSHOT 158

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Immune Checkpoint Drugs in Oncology: Analytical Tool

Immune Checkpoint Drugs in Oncology: Analytical Tool

  • $ 8096
  • Industry report
  • August 2016
  • by Bioseeker

Analytical Tools are cancer area specific intelligence and surveillance toolkits within a select number of hot, emerging cancer therapy areas. They are designed to empower biotech/pharma professionals ...

Radiation Oncology Market: By Technolgy (External (IGRT, IMRT, VMAT, & Stereotactic), Brachytherapy (LDR & HDR), & Systemic Radiotherapy), Product (Cyberknife, Gammaknife, Linac, Proton Beam), & By Application & By Region-Forecast (2016-2021)

Radiation Oncology Market: By Technolgy (External (IGRT, IMRT, VMAT, & Stereotactic), Brachytherapy (LDR & HDR), & Systemic Radiotherapy), Product (Cyberknife, Gammaknife, Linac, Proton Beam), & By Application & By Region-Forecast (2016-2021)

  • $ 5250
  • Industry report
  • August 2016
  • by Industry ARC

Radiation oncology or radiation therapy is therapy to stop cancer cells from multiplying and cancer to spread and result into fatality. Radiation oncology uses ionizing radiation to control or kill malignant ...

Anal Cancer  - Market Insights, Epidemiology and Market Forecast-2023

Anal Cancer  - Market Insights, Epidemiology and Market Forecast-2023

  • $ 4950
  • Industry report
  • November 2016
  • by Delve Insight

Note*: This report requires 5 business days to complete. DelveInsight’s Anal Cancer - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.